Indeed, in Matrigel-growing solid tumors of different origin, as well as in xenografts, Cisplatin has been reported to up-regulate VEGF and its cognate receptor VEGFR1/Flt, paradoxically favoring tumor growth and neo-angiogenesis [42]. Here, FLT1 is linked to neoplasm.